CARDEAS PHARMA Corp
Industry: Pharmaceuticals (See others in industry)
Address:
2025 1 St Avenue Suite 1200
Seattle, WA, 98121
Phone: 206-973-1026
Seattle, WA, 98121
Phone: 206-973-1026
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2015-04-09 | Amended | $37,500,000 | $3,500,000 | Equity Only | 06b | SEC link |
| 2013-05-23 | New | $34,000,000 | $34,000,000 | Equity Only | 06 | SEC link |
| 2012-09-27 | Amended | $10,527,201 | $2,991,213 | Equity Only | 06 | SEC link |
| 2012-03-16 | Amended | $7,535,988 | $1,635,993 | Equity Only | 06 | SEC link |
| 2011-12-30 | New | $5,899,995 | $5,899,995 | Equity Only | 06 | SEC link |
| 2011-02-22 | New | $1,001,523 | $1,001,523 | Equity Only | 06 | SEC link |
| 2010-08-10 | New | $20,100 | $20,100 | Equity Only | 06 | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Aaron Davidson | Director |
| Robert De Gavre | Director |
| Stephen Graham | Executive |
| Kevin Kinsella | Director |
| Peter Moldt | Director |
| A. Bruce Montgomery | Director, Executive, Promoter |
| Anthony Scullion | Director |
| Melissa Yeager | Executive, Promoter |